BAUM CHARLES M

CIK 00015798247 companiesWATERTOWN, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001579824

Recent Transactions

50 trades

Award
Acrivon Therapeutics, Inc.$ACRV
Stock Option (Right to Buy)
2026-06-17+20,275→ 20,275 total
Award
PMV Pharmaceuticals, Inc.$PMVP
Stock Option (right to buy)
2026-06-04+42,000→ 42,000 total
Award
Acrivon Therapeutics, Inc.$ACRV
Common Stock
2026-05-18+9,366→ 9,366 total
Award
Acrivon Therapeutics, Inc.$ACRV
Stock Option (Right to Buy)
2025-06-13+20,275→ 20,275 total
Award
PMV Pharmaceuticals, Inc.$PMVP
Stock Option (right to buy)
2025-06-05+33,500→ 33,500 total
Disposition to Issuer
Poseida Therapeutics, Inc.
Stock Option (Right to Buy)
2025-01-08−27,350→ 0 total
Disposition to Issuer
Poseida Therapeutics, Inc.
Stock Option (Right to Buy)
2025-01-08−57,000→ 0 total
Disposition from Tender
Poseida Therapeutics, Inc.
Common Stock
2025-01-08−78,600→ 0 total
Disposition to Issuer
Poseida Therapeutics, Inc.
Stock Option (Right to Buy)
2025-01-08−27,350→ 0 total
Award
Acrivon Therapeutics, Inc.$ACRV
Stock Option (Right to Buy)
2024-06-20+20,275→ 20,275 total
Award
Poseida Therapeutics, Inc.
Stock Option (Right to buy)
2024-06-17+27,350→ 27,350 total
Award
Poseida Therapeutics, Inc.
Common Stock
2024-06-17+19,650→ 78,600 total
Award
PMV Pharmaceuticals, Inc.$PMVP
Stock Option (right to buy)
2024-06-06+67,500→ 67,500 total
Disposition to Issuer
Mirati Therapeutics, Inc.
Common Stock
2024-01-23−94,057→ 20,425 total
Disposition to Issuer
Mirati Therapeutics, Inc.
Common Stock
2024-01-23−20,425→ 0 total
Disposition to Issuer
Mirati Therapeutics, Inc.
Option to Purchase Common Stock
2024-01-23−7,520→ 0 total
Disposition to Issuer
Mirati Therapeutics, Inc.
Option to Purchase Common Stock
2024-01-23−69,258→ 0 total
Disposition to Issuer
Mirati Therapeutics, Inc.
Option to Purchase Common Stock
2024-01-23−100,273→ 0 total
Disposition to Issuer
Mirati Therapeutics, Inc.
Option to Purchase Common Stock
2024-01-23−81,458→ 0 total
Disposition to Issuer
Mirati Therapeutics, Inc.
Common Stock
2024-01-23−123,389→ 114,482 total
Disposition to Issuer
Mirati Therapeutics, Inc.
Option to Purchase Common Stock
2024-01-23−1,559→ 0 total
Disposition to Issuer
Mirati Therapeutics, Inc.
Option to Purchase Common Stock
2024-01-23−111,652→ 0 total
Disposition to Issuer
Mirati Therapeutics, Inc.
Option to Purchase Common Stock
2024-01-23−168,441→ 0 total
Disposition to Issuer
Mirati Therapeutics, Inc.
Option to Purchase Common Stock
2024-01-23−178,052→ 0 total
Award
Mirati Therapeutics, Inc.
Common Stock
2023-12-29$58.75/sh+20,425→ 247,700 total
Award
Mirati Therapeutics, Inc.
Common Stock
2023-08-09$37.00/sh+54,054→ 227,275 total
Award
Acrivon Therapeutics, Inc.$ACRV
Stock Option (Right to Buy)
2023-06-22+32,500→ 32,500 total
Award
Poseida Therapeutics, Inc.
Common Stock
2023-06-15+19,650→ 58,950 total
Award
Poseida Therapeutics, Inc.
Stock Option (Right to buy)
2023-06-15+27,350→ 27,350 total
Award
PMV Pharmaceuticals, Inc.$PMVP
Stock Option (right to buy)
2023-06-08+21,500→ 21,500 total
Award
Mirati Therapeutics, Inc.
Common Stock
2023-01-20+4,444→ 173,221 total
Award
Mirati Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2023-01-20+7,520→ 7,520 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2023-01-04$46.60/sh−3,648→ 168,777 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2022-12-21$40.42/sh−9,092→ 172,425 total
Award
Mirati Therapeutics, Inc.
Common Stock
2022-12-19+53,618→ 181,517 total
Exercise/Conversion
Mirati Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2022-11-28−69,256→ 69,258 total
Exercise/Conversion
Mirati Therapeutics, Inc.
Common Stock
2022-11-28$17.41/sh+69,256→ 197,155 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2022-11-28$100.00/sh−69,256→ 127,899 total
Award
Poseida Therapeutics, Inc.
Common Stock
2022-06-16+39,300→ 39,300 total
Award
Poseida Therapeutics, Inc.
Stock Option (Right to Buy)
2022-06-16+57,000→ 57,000 total
Award
PMV Pharmaceuticals, Inc.$PMVP
Stock Option (right to buy)
2022-06-02+19,500→ 19,500 total
Exercise/Conversion
Mirati Therapeutics, Inc.
Common Stock
2022-01-18$27.00/sh+3,703→ 130,416 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2022-01-18$120.48/sh−2,517→ 127,899 total
Exercise/Conversion
Mirati Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2022-01-18−3,703→ 178,052 total
Award
Mirati Therapeutics, Inc.
Common Stock
2022-01-14+25,543→ 126,713 total
Award
Mirati Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2022-01-14+42,325→ 42,325 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2022-01-04$147.73/sh−4,045→ 101,239 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2022-01-04$149.09/sh−69→ 101,170 total
Gift
Mirati Therapeutics, Inc.
Common Stock
2021-12-16−7,430→ 105,284 total
Exercise/Conversion
Mirati Therapeutics, Inc.
Common Stock
2021-12-03$8.49/sh+47,204→ 159,918 total

Companies

Recent Filings

Address

C/O ACRIVON THERAPEUTICS, INC. 480 ARSENAL WAY, SUITE 100

WATERTOWN, MA, 02472

View on SEC.gov